Vera Therapeutics Q3 Revenue Tops Estimates by $6.88 Million
Photo: TokenPost
Vera Therapeutics, Inc. (NASDAQ: VERA) posted $10.2 million in third-quarter revenue, beating estimates by $6.88 million, while its GAAP loss per share was narrower than expected. The company’s GAAP loss was $1.30 per share, 32 cents narrower than estimates. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
